496 related articles for article (PubMed ID: 17068485)
1. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9.
Lebre MC; van der Aar AM; van Baarsen L; van Capel TM; Schuitemaker JH; Kapsenberg ML; de Jong EC
J Invest Dermatol; 2007 Feb; 127(2):331-41. PubMed ID: 17068485
[TBL] [Abstract][Full Text] [Related]
2. Cultured human melanocytes express functional toll-like receptors 2-4, 7 and 9.
Yu N; Zhang S; Zuo F; Kang K; Guan M; Xiang L
J Dermatol Sci; 2009 Nov; 56(2):113-20. PubMed ID: 19740627
[TBL] [Abstract][Full Text] [Related]
3. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M
Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290
[TBL] [Abstract][Full Text] [Related]
4. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
5. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
[TBL] [Abstract][Full Text] [Related]
7. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma.
Erridge C; Burdess A; Jackson AJ; Murray C; Riggio M; Lappin D; Milligan S; Spickett CM; Webb DJ
Eur J Clin Invest; 2008 Oct; 38(10):713-20. PubMed ID: 18837796
[TBL] [Abstract][Full Text] [Related]
8. Expression and role of Toll-like receptors on human umbilical cord mesenchymal stromal cells.
Chen D; Ma F; Xu S; Yang S; Chen F; Rong L; Chi Y; Zhao Q; Lu S; Han Z; Pang A; Han Z
Cytotherapy; 2013 Apr; 15(4):423-33. PubMed ID: 23352460
[TBL] [Abstract][Full Text] [Related]
9. Activation of toll-like receptors 2, 3 or 5 induces matrix metalloproteinase-1 and -9 expression with the involvement of MAPKs and NF-kappaB in human epidermal keratinocytes.
Lee Y; Kim H; Kim S; Kim KH; Chung JH
Exp Dermatol; 2010 Aug; 19(8):e44-9. PubMed ID: 19758322
[TBL] [Abstract][Full Text] [Related]
10. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
11. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis.
Mishra BB; Mishra PK; Teale JM
J Neuroimmunol; 2006 Dec; 181(1-2):46-56. PubMed ID: 17011049
[TBL] [Abstract][Full Text] [Related]
12. TLR3-mediated NF-{kappa}B signaling in human esophageal epithelial cells.
Lim DM; Narasimhan S; Michaylira CZ; Wang ML
Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1172-80. PubMed ID: 19779021
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells.
Schaefer TM; Desouza K; Fahey JV; Beagley KW; Wira CR
Immunology; 2004 Jul; 112(3):428-36. PubMed ID: 15196211
[TBL] [Abstract][Full Text] [Related]
14. Ligand-induced differential cross-regulation of Toll-like receptors 2, 4 and 5 in intestinal epithelial cells.
van Aubel RA; Keestra AM; Krooshoop DJ; van Eden W; van Putten JP
Mol Immunol; 2007 Jul; 44(15):3702-14. PubMed ID: 17493681
[TBL] [Abstract][Full Text] [Related]
15. Chemokine expression by human keratinocyte cell lines after activation of Toll-like receptors.
Olaru F; Jensen LE
Exp Dermatol; 2010 Aug; 19(8):e314-6. PubMed ID: 20100199
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of Toll-like receptors in chicken heterophils.
Kogut MH; Iqbal M; He H; Philbin V; Kaiser P; Smith A
Dev Comp Immunol; 2005; 29(9):791-807. PubMed ID: 15936435
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.
Sukkar MB; Xie S; Khorasani NM; Kon OM; Stanbridge R; Issa R; Chung KF
J Allergy Clin Immunol; 2006 Sep; 118(3):641-8. PubMed ID: 16950283
[TBL] [Abstract][Full Text] [Related]
18. Expression profile of Toll‑like receptors in human breast cancer.
Shi S; Xu C; Fang X; Zhang Y; Li H; Wen W; Yang G
Mol Med Rep; 2020 Feb; 21(2):786-794. PubMed ID: 31789409
[TBL] [Abstract][Full Text] [Related]
19. TLR activation pathways in HIV-1-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent.
Mempel M; Voelcker V; Köllisch G; Plank C; Rad R; Gerhard M; Schnopp C; Fraunberger P; Walli AK; Ring J; Abeck D; Ollert M
J Invest Dermatol; 2003 Dec; 121(6):1389-96. PubMed ID: 14675188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
